Cbfβ is involved in maturation of all lineages of hematopoietic cells during embryogenesis except erythroid

Blood Cells, Molecules, and Diseases

Volumn 30, Issue 2, 2003, Pages 164-169

  Kundu, Mondira ^a   Liu, P Paul ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE BINDING FACTOR; CORE BINDING FACTOR BETA; GREEN FLUORESCENT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; FETUS; HEMATOPOIETIC CELL; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; TRANSGENIC MOUSE;

GENETTA;

EID: 0037624909     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-9796(03)00030-5     Document Type: Article

References (31)

1. Kundu M., Chen A., Anderson S., Kirby M., Xu L., Castilla L.H., Bodine D., Liu P.P. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11. Blood. 100:2002;2449-2456.
2. Adya N., Castilla L.H., Liu P.P. Function of CBFbeta/Bro proteins. Semin. Cell Dev. Biol. 11:2000;361-368.
3. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci USA. 93:1996;3444-3449.
4. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321-330.
5. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1 a transcriptional activator of osteoblast differentiation . Cell. 89:1997;747-754.
6. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:1997;755-764.
7. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:1997;765-771.
8. Banerjee C., McCabe L.R., Choi J.Y., Hiebert S.W., Stein J.L., Stein G.S., Lian J.B. Runt homology domain proteins in osteoblast differentiation AML3/CBFA1 is a major component of a bone-specific complex . J. Cell Biochem. 66:1997;1-8.
9. Li Q.L., Ito K., Sakakura C., Fukamachi H., Inoue K., Chi X.Z., Lee K.Y., Nomura S., Lee C.W., Han S.B., Kim H.M., Kim W.J., Yamamoto H., Yamashita N., Yano T., Ikeda T., Itohara S., Inazawa J., Abe T., Hagiwara A., Yamagishi H., Ooe A., Kaneda A., Sugimura T., Ushijima T., Bae S.C., Ito Y. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 109:2002;113-124.
10. Levanon D., Bettoun D., Harris-Cerruti C., Woolf E., Negreanu V., Eilam R., Bernstein Y., Goldenberg D., Xiao C., Fliegauf M., Kremer E., Otto F., Brenner O., Lev-Tov A., Groner Y. The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21:2002;3454-3463.
11. Inoue K., Ozaki S., Shiga T., Ito K., Masuda T., Okado N., Iseda T., Kawaguchi S., Ogawa M., Bae S.C., Yamashita N., Itohara S., Kudo N., Ito Y. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nature Neurosci. 5:2002;946-954.
12. Warren A.J., Bravo J., Williams R.L., Rabbitts T.H. Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta. EMBO J. 19:2000;3004-3015.
13. Tahirov T.H., Inoue-Bungo T., Morii H., Fujikawa A., Sasaki M., Kimura K., Shiina M., Sato K., Kumasaka T., Yamamoto M., Ishii S., Ogata K. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta. Cell. 104:2001;755-767.
14. Huang X., Peng J.W., Speck N.A., Bushweller J.H. Solution structure of core binding factor beta and map of the CBF alpha binding site. Nature Struct. Biol. 6:1999;624-627.
15. Goger M., Gupta V., Kim W.Y., Shigesada K., Ito Y., Werner M.H. Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBF beta. Nature Struct. Biol. 6:1999;620-623.
16. Wang Q., Stacy T., Miller J.D., Lewis A.F., Gu T.L., Huang X., Bushweller J.H., Bories J.C., Alt F.W., Ryan G., Liu P.P., Wynshaw-Boris A., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell. 87:1996;697-708.
17. Sasaki K., Yagi H., Bronson R.T., Tominaga K., Matsunashi T., Deguchi K., Tani Y., Kishimoto T., Komori T. Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta. Proc. Natl. Acad. Sci. USA. 93:1996;12359-12363.
18. Kundu M., Javed A., Jeon J.P., Horner A., Shum L., Eckhaus M., Muenke M., Lian J.B., Yang Y., Nuckolls G.H., Stein G.S., Liu P.P. Cbfbeta interacts with Runx2 and has a critical role in bone development. Nature Genet. 32:2002;639-644.
19. Yoshida C.A., Furuichi T., Fujita T., Fukuyama R., Kanatani N., Kobayashi S., Satake M., Takada K., Komori T. Core-binding factor beta interacts with Runx2 and is required for skeletal development. Nature Genet. 32:2002;633-638.
20. Miller J., Horner A., Stacy T., Lowrey C., Lian J.B., Stein G., Nuckolls G.H., Speck N.A. The core-binding factor beta subunit is required for bone formation and hematopoietic maturation. Nature Genet. 32:2002;645-649.
21. North T., Gu T.L., Stacy T., Wang Q., Howard L., Binder M., Marin-Padilla M., Speck N.A. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 126:1999;2563-2575.
22. North T.E., de Bruijn M.F., Stacy T., Talebian L., Lind E., Robin C., Binder M., Dzierzak E., Speck N.A. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity. 16:2002;661-672.
23. Miyoshi H., Shimizu K., Kozu T., Maseki N., Kaneko Y., Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. USA. 88:1991;10431-10434.
24. Liu P., Tarle S.A., Hajra A., Claxton D.F., Marlton P., Freedman M., Siciliano M.J., Collins F.S. Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. Science. 261:1993;1041-1044.
25. Mundlos S., Otto F., Mundlos C., Mulliken J.B., Aylsworth A.S., Albright S., Lindhout D., Cole W.G., Henn W., Knoll J.H., Owen M.J., Mertelsmann R., Zabel B.U., Olsen B.R. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 89:1997;773-779.
26. Castilla L.H., Wijmenga C., Wang Q., Stacy T., Speck N.A., Eckhaus M., Marin-Padilla M., Collins F.S., Wynshaw-Boris A., Liu P.P. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell. 87:1996;687-696.
27. Castilla L.H., Garrett L., Adya N., Orlic D., Dutra A., Anderson S., Owens J., Eckhaus M., Bodine D., Liu P.P. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia. Nature Genet. 23:1999;144-146.
28. Yano M., Iwama A., Nishio H., Suda J., Takada G., Suda T. Expression and function of murine receptor tyrosine kinases, TIE and TEK, in hematopoietic stem cells. Blood. 89:1997;4317-4326.
29. Schlaeger T.M., Bartunkova S., Lawitts J.A., Teichmann G., Risau W., Deutsch U., Sato T.N. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc. Natl. Acad. Sci. USA. 94:1997;3058-3063.
30. Taniuchi I., Osato M., Egawa T., Sunshine M.J., Bae S.C., Komori T., Ito Y., Littman D.R. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell. 111:2002;621-633.
31. Hayashi K., Natsume W., Watanabe T., Abe N., Iwai N., Okada H., Ito Y., Asano M., Iwakura Y., Habu S., Takahama Y., Satake M. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells. J. Immunol. 165:2000;6816-6824.